All News

Patients recorded their symptoms and use of acute medications in a headache diary.

Elizabeth Ruzzo, PhD, founder and CEO of Adyn, discusses the impact of the reversal of Roe v. Wade and how it will affect pharmacies.

As part of the submission, the companies have also requested priority review with the FDA for elacestrant in patients with ER+/HER2- advanced or metastatic breast cancer.

Semaglutide (Wegovy) is indicated as an adjunct to a reduced calorie diet and increased physical activity for chronic weight management in adult patients.

Migraine Be KoooL is intended to provide relief from headaches, fever, muscle aches, sprains, and over-exertion.

Olopatadine stabilizes ocular mast cells to prevent histamine release by allergens.

Infection in pregnancy increases the risk for preterm delivery and other adverse pregnancy outcomes, including stillbirth.

Clorazepate dipotassium tablets are for the management of anxiety disorders or for the short-term relief of symptoms.

Investigators studied the efficacy and safety of eptinezumab-jjmr in the 100 mg and 300 mg intravenous infusion dosages in individuals with 2 to 4 documented unsuccessful prior preventive treatment failures for migraine in the past 10 years.

This month features Ozempic, Igalmi, and Triumeq PD.

This month, we reviewed key topics and interviews from the American Society of Clinical Oncology 2022 Annual Meeting.

Levetiracetam is an anticonvulsant used to treat epileptic seizures.

Dual action for neuropathy and neuralgia pain relief as well as for use in diabetes-related nerve pain and shingles.

The FDA approved the first vaccine for dengue disease in May 2019.

Folate receptor α may be an important treatment target for ovarian tumors.

June 27 is National HIV Testing Day, so Pharmacy Times® sat down with Brad McElya, PharmD, director of Specialty Health Solutions at Walgreens, to discuss the importance of HIV testing.

The researchers noted that new therapies have faced challenges because of this knowledge gap in CHD.

The Sanofi-GSK vaccine demonstrated a favorable safety and tolerability profile throughout stage 1 and stage 2 of the VAT08 trial, according to the researchers.

Lenvima (lenvatinib) is approved for the treatment of thyroid cancer, renal cell carcinoma, hepatocellular carcinoma, and endometrial carcinoma.

Clinical evaluation dictates the need for preventive therapy and advice on exercising and participation in competitive sports, according to the European Society of Cardiology.

Submission is based on phase 2 study results evaluating atogepant in adults who met the primary endpoint of a statistically significant reduction from the baseline compared with a placebo.

Lisocabtagene maraleucel (liso-cel, Breyanzi; Bristol Myers Squibb) approved for the second-line treatment of patients with large B-cell lymphoma (LBCL), including diffuse large B-cell lymphoma not otherwise specified, high-grade B-cell lymphoma, primary mediastinal LBCL, and follicular lymphoma grade 3B.

We spoke with Carlie Traylor, PharmD, of the National Community Pharmacy Association to learn about a fellowship program offered by NCPA and CPESN

Venlafaxine Extended-Release (Effexor XR) is indicated for the treatment of major depressive disorder, generalized anxiety disorder, social anxiety disorder, and panic disorder.

Suzanne Soliman, PharmD, BCMAS welcomes Sonia T. Oskouei, PharmD, BCMAS, DPLA to discuss biosimilars within the pharmacy industry.

Analysis results expand understanding of the impact of the company’s medicines in early stages with the goal or providing patients with durable and robust outcomes from their first treatment.

This is the first RSV vaccination candidate to show clinically meaningful and statistically significant efficacy in adults aged 60 years and older.